Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases [PDF]
Introduction: Ospemifene (Osphena, Shionogi Inc, Florham, NJ, USA) is an estrogen agonist and antagonist approved by the U.S. Federal Drug Administration for the treatment of “moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due ...
Andrew T. Goldstein, MD +1 more
doaj +4 more sources
Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause [PDF]
During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj +2 more sources
Vulvar Fibroadenoma: A Rare Differential Diagnosis of a Vulvar Mass. [PDF]
ABSTRACT Vulvar fibroadenoma is a rare benign tumor arising from mammary‐type tissue or mammary‐like anogenital glands. A 46‐year‐old Asian woman presented with a slowly enlarging painful labial mass and a history of gynecological disorders. Excision confirmed fibroadenoma, highlighting its inclusion in the differential diagnosis of vulvar masses.
Nili F, Nozheh A, Norouzi M, Gilani A.
europepmc +2 more sources
High diagnostic concordance between vulvar and cervical samples for human papillomavirus detection: a cross-sectional study [PDF]
Low compliance with clinician-collected cervical sampling and implementation barriers in resource-limited settings limit human papillomavirus (HPV)-based cervical cancer prevention. Vulvar sampling is non-invasive and easier to perform, but its agreement
Shuying Miao +6 more
doaj +2 more sources
Labia Majora Symmetrization Using De-epithelialized Deep External Pudendal Artery Tubular Flap [PDF]
Summary:. This case report presents a novel technique for reconstructing posttraumatic asymmetrical labia majora using a deep external pudendal artery tubular flap.
Osvaldo J. Pereira, MD +2 more
doaj +2 more sources
Clinical presentation differences of lichen sclerosus in pre- and post-menopausal women [PDF]
Objective: To evaluate the clinical differences in the presentation of vulvar lichen sclerosus in pre- and postmenopausal women, aiming to provide insights to improve disease management and promote the health and well-being of affected patients. Methods:
Fernanda Villar Fonseca +6 more
doaj +3 more sources
One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trial [PDF]
Purpose To assess the 12-month efficacy of a novel non-ablative dual Nd:YAG/Er:YAG laser therapy for vulvar lichen sclerosus (LS) and to evaluate the impact of crossover laser treatment following initial topical corticosteroid therapy. Methods This study
Marianne Gamper +3 more
doaj +2 more sources
Dermoscopy for monitoring therapeutic response to hybrid cooperative complexes of hyaluronic acid in women with vulvar lichen sclerosus and atrophy [PDF]
IntroductionVulvar Lichen Sclerosus (VLS) is a chronic relapsing inflammatory disease involving the anogenital region, resulting in vulvar atrophy and distressing symptoms.
Giulio Rizzetto +12 more
doaj +2 more sources
Clinical, Biochemical and Pathological Findings in Symptomatic and Asymptomatic Bitches With Intrauterine Content. [PDF]
ABSTRACT Intrauterine contents are a common ultrasound finding in bitches, with variable significance. Clinical, analytical and histopathological findings were compared between symptomatic and asymptomatic bitches with intrauterine contents that underwent ovariohysterectomy. In this cross‐sectional study, the majority were symptomatic (87.9%, 123/140).
Falceto MV +9 more
europepmc +2 more sources
Successful Treatment of Vulvar Lichen Sclerosus Using Microfiltered and Preconditioned Suspension of Autologous Adipose‐Derived Stem Cells With Photothermal Biomodulation: A Case Report [PDF]
Vulvar lichen sclerosus is a chronic, inflammatory, autoimmune mucocutaneous disease characterized by hypopigmentation, skin sclerosis, and atrophy. Injections with microfiltered and preconditioned suspension of autologous adipose–derived stem cells are ...
Paolo Mezzana, Hernán Pinto
doaj +2 more sources

